Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD - Wikidata - awgldk - TriplyDB

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

http://www.wikidata.org/entity/Q37069998

about

Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.Blunted transcriptional response to skeletal muscle ischemia in rats with chronic kidney disease: potential role for impaired ischemia-induced angiogenesis.Interaction of Soluble CXC Ligand 16 and Cardiac Injury Markers in Hemodialysis Patients.Cardiovascular disease in haemodialysis: role of the intravascular innate immune system.INfluence of Successful Periodontal Intervention in REnal Disease (INSPIRED): study protocol for a randomised controlled pilot clinical trial.Inflammation Relates to Chronic Behavioral and Neurological Symptoms in Military Personnel with Traumatic Brain Injuries.The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease.Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expression.Intravital imaging of the kidney in a rat model of salt-sensitive hypertension.The Landscape of Diabetic Kidney Disease in the United States.Evaluation of the Predictive Value of the Serum Calcium-Magnesium Ratio for All-Cause and Cardiovascular Mortality in Incident Dialysis Patients.Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.Relations of established aging biomarkers (IL-6, D-dimer, s-VCAM) to glomerular filtration rate and mortality in community-dwelling elderly adults.

P2860

Q33611989-F44C1919-D2DC-45E8-AD5E-54D740875792 Q33704372-48D9AD95-8077-4682-BD50-FDC9FE059E97 Q36152748-E9A324DF-6455-4473-9EAC-E3AF402A564A Q36284638-6D74865E-5C52-4C8E-A669-4446DE5A7214 Q38717039-C5B6DF85-64A3-40E6-A1A1-82621121ACAB Q39151839-0EA3948A-9D1A-4EDF-BBDB-0D4F8305B052 Q47100087-0BCE7628-EA05-4F9C-BB4C-649DEF4B83C9 Q47109309-35D987CA-CC3B-463B-B88F-EAFDC7308878 Q47235026-B0CF3CDA-0442-403B-B16F-33EA71436EF7 Q47307137-32A7AD3A-220C-4E69-9BB8-49A4FC7D8701 Q48283242-B2A277E2-94C8-46D2-B3E1-AEDC1189882E Q49862755-50F0CC98-3FC1-491C-8FC1-CB99E4D36A2C Q49987850-E9A7E29D-7821-47DB-9C8E-894238474FB8 Q52558292-65E671EC-E4A6-42D2-80F5-BB881952CD3B Q55483428-FEA81F38-A857-4667-A40B-FD8FD2B31479

P2860

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

http://www.wikidata.org/entity/Q37069998

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

@en

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.

@nl

type

label

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

@en

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.

@nl

prefLabel

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

@en

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.

@nl

P1433

Q37069998-4817B37F-AAD7-47FC-B7B8-DBB696BF5B6E

P1476

Q37069998-0DDBAAB4-5EC7-44D8-B1DE-C270D9416EA1

P2093

Q37069998-1FCDDD7E-9E8C-4E62-8F17-00FDD54479A4

Q37069998-55B12959-DE8E-44B6-BF8B-C95B50808571

Q37069998-79D27151-F8A2-49FF-B9F9-3B17326EC546

Q37069998-7A740231-9125-4F88-B9DD-8A09419C45B2

Q37069998-D9F3CCA8-AE46-4C56-A958-DDA799C55303

Q37069998-F6EAB134-82CE-4577-B500-15BD57B4374A

P2860

Q37069998-04F6C9FC-D947-4148-9277-48ADF8D121D2

Q37069998-0DD38412-0ACD-4F97-A449-F102B9158694

Q37069998-16384F93-80D2-424C-B506-713C1090B402

Q37069998-1E0C7AE1-DABC-4F57-ABD1-61EDA66AE36E

Q37069998-1EC4EE03-2ECD-45B8-B799-D2D3BAA6940F

Q37069998-25417364-1953-4B7F-9CFC-88B81E2982FE

Q37069998-2C54DC4C-0B0D-4B71-9B5D-F23D458FAAC3

Q37069998-31F003E5-59A5-4E8B-9AE0-E22B205A83F4

Q37069998-378BEC54-D7E9-4154-A2DF-61421BE020E6

Q37069998-38174CA7-591B-4D93-B760-E4AB5F2D8900

P304

Q37069998-4E87A1D3-F0C7-4649-9513-033168CEAD99

P31

Q37069998-641EE5FF-AE54-4C7F-9C8B-7950F4ABD8DA

P356

Q37069998-8963F5A1-4C15-4B46-8944-20C58B29D561

P433

Q37069998-E99BDF02-B049-40B4-B9DD-54FE15DF82D6

P478

Q37069998-49C48740-BE81-48B5-B916-BFAF593B2A70

P50

Q37069998-9A5A3889-BA72-4D36-A592-17936EFC4D0E

Q37069998-D448C8EA-32D4-46FF-A65D-4BD0C841C3B1

Q37069998-EEC580A5-3E27-4A87-A168-1A4394458427

P577

Q37069998-832D173B-00AE-4FDF-AFE7-614AFABFCB57

P698

Q37069998-0CFC424D-F4B9-455A-B42E-AE0E3B6A5233

P921

Q37069998-C85F0CDD-9C37-4BF2-AF7F-6A608DA8ECA9

Q37069998-FAB43A62-AB5B-46E7-AEB9-E49925DA018F

P932

Q37069998-F7677779-1924-4FF9-A163-676487AB462B

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

@en

P2093

Abdul Rashid Qureshi

http://www.w3.org/2001/XMLSchema#string

Anna Machowska

http://www.w3.org/2001/XMLSchema#string

Jia Sun

http://www.w3.org/2001/XMLSchema#string

Jonas Axelsson

http://www.w3.org/2001/XMLSchema#string

Karin Lindström

http://www.w3.org/2001/XMLSchema#string

Peter Bárány

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Subclinical atherosclerosis measures for cardiovascular prediction in CKD

High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients

Cardiovascular disease in chronic renal insufficiency.

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly.

Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.

Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.

Risk Score to Predict 1-Year Mortality after Haemodialysis Initiation in Patients with Stage 5 Chronic Kidney Disease under Predialysis Nephrology Care

Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction.

P304

1163-1172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.10441015

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Peter Stenvinkel

Olof Heimbürger

P577

2016-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27281698

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4934843

http://www.w3.org/2001/XMLSchema#string